» Articles » PMID: 23843810

An Update on Plant Derived Anti-androgens

Overview
Publisher Brieflands
Specialty Endocrinology
Date 2013 Jul 12
PMID 23843810
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-androgens are an assorted group of drugs and compounds that reduce the levels or activity of androgen hormones within the human body. Disease states in which this is relevant include polycystic ovarian syndrome, hirsutism, acne, benign prostatic hyperplasia, and endocrine related cancers such as carcinoma of the prostate. We provide an overview and discussion of the use of anti-androgen medications in clinical practice and explore the increasing recognition of the benefits of plant-derived anti-androgens, for example, spearmint tea in the management of PCOS, for which some evidence about efficacy is beginning to emerge. Other agents covered include red reishi, which has been shown to reduce levels 5-alpha reductase, the enzyme that facilitates conversion of testosterone to dihydrotestosterone (DHT); licorice, which has phytoestrogen effects and reduces testosterone levels; Chinese peony, which promotes the aromatization of testosterone into estrogen; green tea, which contains epigallocatechins and also inhibits 5-alpha reductase, thereby reducing the conversion of normal testosterone into the more potent DHT; black cohosh, which has been shown to kill both androgenresponsive and non-responsive human prostate cancer cells; chaste tree, which has a reduces prolactin from the anterior pituitary; and saw palmetto extract, which is used as an anti-androgen although it shown no difference in comparison to placebo in clinical trials.

Citing Articles

Association of Herbal Tea and Follicle-Stimulating Hormone, Anthropometric Parameters, and Fasting Blood Glucose Levels Among Polycystic Ovarian Syndrome Women: A Systematic Review and Meta-Analysis of Clinical Trials.

Abbasi E, Hajhashemy Z, Askari G, Saneei P Clin Nutr Res. 2024; 13(3):201-213.

PMID: 39165287 PMC: 11333146. DOI: 10.7762/cnr.2024.13.3.201.


Functional Foods in Dermatology.

Strouphauer E, Parke M, Perez-Sanchez A, Tantry E, Katta R Dermatol Pract Concept. 2023; 13(4).

PMID: 37992371 PMC: 10656176. DOI: 10.5826/dpc.1304a256.


Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope.

Saranyutanon S, Srivastava S, Pai S, Singh S, Singh A Cancers (Basel). 2019; 12(1).

PMID: 31877956 PMC: 7016833. DOI: 10.3390/cancers12010051.


Herbal Teas and their Health Benefits: A Scoping Review.

Poswal F, Russell G, Mackonochie M, MacLennan E, Adukwu E, Rolfe V Plant Foods Hum Nutr. 2019; 74(3):266-276.

PMID: 31243622 DOI: 10.1007/s11130-019-00750-w.


Apoptosis: A Target for Anticancer Therapy.

Pfeffer C, Singh A Int J Mol Sci. 2018; 19(2).

PMID: 29393886 PMC: 5855670. DOI: 10.3390/ijms19020448.


References
1.
Boyle P, Robertson C, Lowe F, Roehrborn C . Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004; 93(6):751-6. DOI: 10.1111/j.1464-410X.2003.04735.x. View

2.
Wilt T, Ishani A, Mac Donald R . Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002; (3):CD001423. DOI: 10.1002/14651858.CD001423. View

3.
Webster D, He Y, Chen S, Pauli G, Farnsworth N, Wang Z . Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. Biochem Pharmacol. 2010; 81(1):170-7. PMC: 2993511. DOI: 10.1016/j.bcp.2010.09.013. View

4.
Bent S, Kane C, Shinohara K, Neuhaus J, Hudes E, Goldberg H . Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006; 354(6):557-66. DOI: 10.1056/NEJMoa053085. View

5.
Tamir S, Eizenberg M, Somjen D, IZRAEL S, Vaya J . Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol. 2001; 78(3):291-8. DOI: 10.1016/s0960-0760(01)00093-0. View